Company Filing History:
Years Active: 2016-2022
Title: Galit Eisenberg: Innovator in Cancer Therapy
Introduction
Galit Eisenberg is a prominent inventor based in Modiin, Israel. She has made significant contributions to the field of immunotherapy, particularly in cancer treatment. With a total of 4 patents to her name, her work focuses on innovative methods that enhance T cell modulation for improved patient outcomes.
Latest Patents
Eisenberg's latest patents include groundbreaking methods for cancer therapy using isolated NTB-A ectodomain polypeptides. These inventions provide compositions and methods for improved T cell modulation both ex vivo and in vivo. Specifically, her work aims to treat cancer and other pathologies by utilizing soluble NTB-A polypeptides or their agonists. This approach not only targets cancer patients but also seeks to prevent and treat cytopenia in susceptible individuals. Additionally, her patents encompass cell compositions and methods for cancer therapy, further emphasizing her commitment to advancing immunotherapy.
Career Highlights
Galit Eisenberg is associated with Hadasit Medical Research Services and Development Ltd., where she continues to innovate in the field of medical research. Her dedication to improving cancer treatment through scientific research has positioned her as a key figure in her field.
Collaborations
Eisenberg collaborates with notable colleagues, including Michal Lotem and Arthur Machlenkin. These partnerships enhance her research efforts and contribute to the development of effective cancer therapies.
Conclusion
Galit Eisenberg's work in cancer therapy exemplifies the impact of innovative research in the medical field. Her patents and collaborations reflect her commitment to improving patient care through advanced immunotherapy techniques.